Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications.
Thoenen
H
H
Department of Neurochemistry, Max Planck Institute for Psychiatry, Martinsried, Germany.
Hughes
R A
RA
Sendtner
M
M
D000818:Animals; D004195:Disease Models, Animal; D016222:Fibroblast Growth Factor 2 / Q000235:genetics / Q000502:physiology / Q000627:therapeutic use; D006133:Growth Substances / Q000502:physiology* / Q000627:therapeutic use*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology / Q000627:therapeutic use; D016472:Motor Neuron Disease / Q000503:physiopathology / Q000628:therapy*; D009046:Motor Neurons / Q000502:physiology*; D005810:Multigene Family; D009414:Nerve Growth Factors / Q000502:physiology* / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000502:physiology* / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000503:physiopathology / Q000628:therapy*
D006133:Growth Substances; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D016222:Fibroblast Growth Factor 2; D007334:Insulin-Like Growth Factor I